Condition: Cystic Fibrosis · Sponsor: Sonya Heltshe
This is a two-part, multi-center, prospective longitudinal, exploratory study of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators and their impact on children with cystic fibrosis (CF).
This description comes directly from the study's public registry record.
Rachael Buckingham · 206-884-7517 · rachael.buckingham@seattlechildrens.org
Anna Mead · 206-884-7531 · anna.mead@seattlechildrens.org
Always discuss trial participation with your own doctor first.
| The Children's Hospital Alabama, University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Stanford University Medical Center | Palo Alto, California, United States | Recruiting |
| Children's Hospital Colorado | Aurora, Colorado, United States | Recruiting |
| Nemours Children's Clinic | Jacksonville, Florida, United States | Recruiting |
| University of Miami | Miami, Florida, United States | Recruiting |
| The Nemours Children's Clinic - Orlando | Orlando, Florida, United States | Recruiting |
| Riley Hospital for Children | Indianapolis, Indiana, United States | Recruiting |
| University of Iowa | Iowa City, Iowa, United States | Recruiting |
| University of Kansas Medical Center | Kansas City, Kansas, United States | Recruiting |
| Boston Children's Hospital | Boston, Massachusetts, United States | Recruiting |
| University of Michigan, Michigan Medicine | Ann Arbor, Michigan, United States | Recruiting |
| Helen DeVos Children's Hospital | Grand Rapids, Michigan, United States | Recruiting |
+ 23 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04509050